{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:55:20Z","timestamp":1781646920642,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the safety of aspirin continuation versus discontinuation in patients undergoing vitreoretinal surgery by assessing hemorrhagic complications and visual outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The review protocol was prospectively registered in PROSPERO (CRD420251270694). A systematic review and meta-analysis was conducted following PRISMA guidelines. PubMed, Scopus, Ovid, and Web of Science were searched from inception through August 31, 2025. Studies comparing aspirin continuation versus discontinuation or no aspirin use in adult patients undergoing vitreoretinal surgery were included. The primary outcome was vitreous hemorrhage. Secondary outcomes included hyphema, subconjunctival hemorrhage, subretinal hemorrhage, choroidal hemorrhage, retinal hemorrhage, and visual acuity changes. Risk ratios (RR) with 95% confidence intervals (CI) were calculated using random-effects models. Quality assessment was performed using the Newcastle-Ottawa Scale, and certainty of evidence was rated using the GRADE framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven studies comprising 2,889 surgical procedures (2,873 patients) were included. Aspirin continuation was not associated with significantly increased risk of vitreous hemorrhage (RR 1.55, 95% CI: 0.73\u20133.29,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.253, I\u00b2=61.7%), hyphema (RR 1.52, 95% CI: 0.56\u20134.17,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.415, I\u00b2=0.0%), subconjunctival hemorrhage (RR 1.20, 95% CI: 0.58\u20132.48,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.622, I\u00b2=0.0%), subretinal hemorrhage (RR 1.06, 95% CI: 0.15\u20137.63,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.956, I\u00b2=82.4%), choroidal hemorrhage (RR 2.07, 95% CI: 0.81\u20135.24,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.127, I\u00b2=0.0%), retinal hemorrhage (RR 1.68, 95% CI: 0.33\u20138.52,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.532, I\u00b2=73.6%), or postoperative visual acuity (MD\u2009=\u20090.26 logMAR, 95% CI: \u22120.005 to 0.52;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.055). Included studies were rated as moderate to high quality on the Newcastle-Ottawa Scale. GRADE certainty of evidence was rated as low to very low across all outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Aspirin continuation appears safe in vitreoretinal surgery, with low risk of hemorrhagic complications. Given aspirin\u2019s thrombotic benefits, it can likely be continued in most patients. However, this conclusion, based on low-certainty evidence, should be interpreted with caution and requires confirmation from high-quality prospective randomized trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00840-3","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:24:51Z","timestamp":1774970691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Do we need to hold aspirin before vitreoretinal surgery? A systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Hashem","family":"Abu Serhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad M.","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameen","family":"Alkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Al-Nawaflh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abu Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"8","key":"840_CR1","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41433-021-01647-2","volume":"36","author":"HA Madi","year":"2022","unstructured":"Madi HA, Keller J. Increasing frequency of hospital admissions for retinal detachment and vitreo-retinal surgery in England 2000\u20132018. Eye (Lond). 2022;36(8):1610\u20134. https:\/\/doi.org\/10.1038\/s41433-021-01647-2.","journal-title":"Eye (Lond)"},{"issue":"6","key":"840_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/bjo.2009.157727","volume":"94","author":"D Mitry","year":"2010","unstructured":"Mitry D, Charteris DG, Fleck BW, Campbell H, Singh J. The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations. Br J Ophthalmol. 2010;94(6):678\u201384. https:\/\/doi.org\/10.1136\/bjo.2009.157727.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"840_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/M19-0953","volume":"171","author":"CW O\u2019Brien","year":"2019","unstructured":"O\u2019Brien CW, Juraschek SP, Wee CC. Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey. Ann Intern Med. 2019;171(8):596\u20138. https:\/\/doi.org\/10.7326\/M19-0953.","journal-title":"Ann Intern Med"},{"issue":"8","key":"840_CR4","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.7326\/M24-0427","volume":"177","author":"M Gupta","year":"2024","unstructured":"Gupta M, Gulati S, Nasir K, Sarraju A. Aspirin Use Prevalence for Cardiovascular Disease Prevention Among U.S. Adults From 2012 to 2021. Ann Intern Med. 2024;177(8):1139\u201341. https:\/\/doi.org\/10.7326\/M24-0427.","journal-title":"Ann Intern Med"},{"issue":"5","key":"840_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/SLA.0b013e318250504e","volume":"255","author":"NS Gerstein","year":"2012","unstructured":"Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively? clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012;255(5):811\u20139. https:\/\/doi.org\/10.1097\/SLA.0b013e318250504e.","journal-title":"Ann Surg"},{"issue":"2","key":"840_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijcard.2014.03.192","volume":"174","author":"RF Alcock","year":"2014","unstructured":"Alcock RF, Reddel CJ, Pennings GJ, Hillis GS, Curnow JL, Brieger DB. The rebound phenomenon after aspirin cessation: the biochemical evidence. Int J Cardiol. 2014;174(2):376\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.192.","journal-title":"Int J Cardiol"},{"issue":"1","key":"840_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1034\/j.1600-0420.2003.00020.x","volume":"81","author":"N Narendran","year":"2003","unstructured":"Narendran N, Williamson TH. The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand. 2003;81(1):38\u201340. https:\/\/doi.org\/10.1034\/j.1600-0420.2003.00020.x.","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"840_CR8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ajo.2010.09.035","volume":"151","author":"J Oh","year":"2011","unstructured":"Oh J, Smiddy WE, Kim SS. Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol. 2011;151(6):934\u2013e9393. https:\/\/doi.org\/10.1016\/j.ajo.2010.09.035.","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"840_CR9","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1001\/archopht.124.11.1558","volume":"124","author":"PN Dayani","year":"2006","unstructured":"Dayani PN, Grand MG. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophthalmol. 2006;124(11):1558\u201365. https:\/\/doi.org\/10.1001\/archopht.124.11.1558.","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"840_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/IIO.0000000000000317","volume":"60","author":"S Idrees","year":"2020","unstructured":"Idrees S, Sridhar J, Kuriyan AE. Perioperative Management of Antiplatelet Therapy in Ophthalmic Surgery. Int Ophthalmol Clin. 2020;60(3):17\u201330. https:\/\/doi.org\/10.1097\/IIO.0000000000000317.","journal-title":"Int Ophthalmol Clin"},{"issue":"2","key":"840_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/08820538.2024.2420969","volume":"40","author":"M Abo Zeid","year":"2025","unstructured":"Abo Zeid M, Elrosasy A, Alkheder A, et al. Do We Need to Hold Aspirin Before Cataract Surgery? A Systematic Review and Meta-Analysis of 65,196 Subjects. Semin Ophthalmol. 2025;40(2):86\u201396. https:\/\/doi.org\/10.1080\/08820538.2024.2420969.","journal-title":"Semin Ophthalmol"},{"key":"840_CR12","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Green S, Cochrane Collaboration, editors. Cochrane Handbook for Systematic Reviews of Interventions. Wiley-Blackwell; 2008.","DOI":"10.1002\/9780470712184"},{"issue":"11","key":"840_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, et al. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. Ann Intern Med. 2015;162(11):777\u201384. https:\/\/doi.org\/10.7326\/m14-2385.","journal-title":"Ann Intern Med"},{"issue":"1","key":"840_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Reviews. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Reviews"},{"key":"840_CR15","doi-asserted-by":"publisher","unstructured":"Ajudani R, Khosravi MH, Ramezani-Binabaj M, Rezaee-Zavareh MS, Alishiri Aagha. Cessation or continuation of aspirin in patients undergoing 20-gauge Pars Plana Vitrectomy due to diabetic retinopathy. GMJ. 2017;6(2). https:\/\/doi.org\/10.31661\/gmj.v6i2.763.","DOI":"10.31661\/gmj.v6i2.763"},{"issue":"3","key":"840_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00417-017-3897-1","volume":"256","author":"C Meillon","year":"2018","unstructured":"Meillon C, Gabrielle PH, Luu M, Aho-Glele LS, Bron AM, Creuzot-Garcher C. Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol. 2018;256(3):461\u20137. https:\/\/doi.org\/10.1007\/s00417-017-3897-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"840_CR17","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1097\/IAE.0b013e31825097ae","volume":"32","author":"M Passemard","year":"2012","unstructured":"Passemard M, Koehrer P, Juniot A, Bron AM, Creuzot-Garcher C, Maintenance of anticoagulant, and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery. Retina. 2012;32(9):1868\u201373. https:\/\/doi.org\/10.1097\/IAE.0b013e31825097ae.","journal-title":"Retina"},{"issue":"4","key":"840_CR18","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1177\/1120672120946930","volume":"31","author":"J Wang","year":"2020","unstructured":"Wang J, Li Q, Zhang Y, et al. Continuation of aspirin therapy before pars plana vitrectomy: Safe or not? Eur J Ophthalmol. 2020;31(4):2013\u20139. https:\/\/doi.org\/10.1177\/1120672120946930.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"840_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00417-019-04554-1","volume":"258","author":"S Bemme","year":"2020","unstructured":"Bemme S, Lauermann P, Striebe NA, et al. Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. Graefes Arch Clin Exp Ophthalmol. 2020;258(5):961\u20139. https:\/\/doi.org\/10.1007\/s00417-019-04554-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"840_CR20","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1442-9071.2011.02575.x","volume":"39","author":"DC Fabinyi","year":"2011","unstructured":"Fabinyi DC, O\u2019Neill EC, Connell PP, Clark JB. Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Exp Ophthalmol. 2011;39(9):878\u201384. https:\/\/doi.org\/10.1111\/j.1442-9071.2011.02575.x.","journal-title":"Clin Exp Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00840-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:15:41Z","timestamp":1781644541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00840-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00840-3","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}